sustain 6 trial semaglutide Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous in the treatment of type 2 diabetes: Insights from the 1–7 trials Frontiers | Cardiovascular Safety and

D.LauretaniF.CorsiA.et al (2007)

It preserves metabolic rate, improves body composition, enhances insulin sensitivity, and creates a better visual result for the same amount of weight lost

Evening Dosing: What the Evidence Shows Clinical trials of semaglutide and tirzepatide did not find statistically significant differences in weight loss between morning and evening injection times in healthy subjects

This can lead to better focus, sharper memory, and overall better cognitive performance

The unit measurements land in a range that is easy to read on standard syringes without creating unnecessarily large injection volumes at maintenance doses